Expression of neural and inflammatory genes correlates with bipolar disorder symptoms: a case control study

Introduction Abnormalities in neurotransmitter systems, cell signaling, mitochondrial function, oxidative stress, and white matter connectivity have been found to contribute to risk of development of bipolar disorders (BD). In this case-control study, we tested association between diagnosis of BD and gene expression of reelin, the reelin receptor [very low-density lipoprotein receptor (VLDLR)], methylation genes DNMT1, DNMT3A, and demethylation genes TET 1 and TET3, brain-derived neurotrophic factor (BDNF), inflammatory cytokines IL-6 and IL-1β and the glucocorticoid receptor gene NR3C1. Methods Twenty individuals diagnosed with subsyndromal BD and 18 healthy controls (HC) participated in the study. Symptom severity was measured by clinician-administered scales. mRNA was measured quantitatively in peripheral blood mononuclear cells (PBMCs) isolated from whole blood drawn at the time of symptom assessment. Statistical analyses used analysis of variance (ANOVA) and partial Spearman correlations controlling for assay set to measure association. Results There were no significant differences in mRNA values between BD and HC, though higher levels of IL-6 were detected in BD when BMI and age were included in the model. However, significant correlations were detected between low mRNA values and higher levels of depressive symptom severity (VLDLR, TET3, IL-6) and manic symptom severity (TET3, IL-6, NR3C1) in the BD group. None of these correlations survived FDR protected significance levels for 27 correlations, which may be due to small sample size. The findings may support associations between subsyndromal manic and depressive symptoms and reelin receptor VLDLR, demethylation gene TET3, cytokines IL-6 and IL-1B, and glucocorticoid receptor NR3C1 linked to abnormal neural growth.

Authors

Institutions

Publication Details

Journal
Frontiers in Psychiatry
Published
2026-11-19
DOI
https://doi.org/10.3389/fpsyt.2026.1870782
Primary Topic
Bipolar Disorder and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Expression of neural and inflammatory genes correlates with bipolar disorder symptoms: a case control study

Alonso Cortez-Resendiz, Daisy Zamora, Alfredo Bellon, Dahlia Mukherjee et al.
Frontiers in Psychiatry
Bipolar Disorder and Treatment
article

Expression of neural and inflammatory genes correlates with bipolar disorder symptoms: a case control study

Alonso Cortez-Resendiz, Daisy Zamora, Alfredo Bellon, Dahlia Mukherjee, Henry W. Sershen, Erika F.H. Saunders, Andrew Yeich, Robert C. Smith, John M. Davis, Mark Volpe
article en

Abstract

Introduction Abnormalities in neurotransmitter systems, cell signaling, mitochondrial function, oxidative stress, and white matter connectivity have been found to contribute to risk of development of bipolar disorders (BD). In this case-control study, we tested association between diagnosis of BD and gene expression of reelin, the reelin receptor [very low-density lipoprotein receptor (VLDLR)], methylation genes DNMT1, DNMT3A, and demethylation genes TET 1 and TET3, brain-derived neurotrophic factor (BDNF), inflammatory cytokines IL-6 and IL-1β and the glucocorticoid receptor gene NR3C1. Methods Twenty individuals diagnosed with subsyndromal BD and 18 healthy controls (HC) participated in the study. Symptom severity was measured by clinician-administered scales. mRNA was measured quantitatively in peripheral blood mononuclear cells (PBMCs) isolated from whole blood drawn at the time of symptom assessment. Statistical analyses used analysis of variance (ANOVA) and partial Spearman correlations controlling for assay set to measure association. Results There were no significant differences in mRNA values between BD and HC, though higher levels of IL-6 were detected in BD when BMI and age were included in the model. However, significant correlations were detected between low mRNA values and higher levels of depressive symptom severity (VLDLR, TET3, IL-6) and manic symptom severity (TET3, IL-6, NR3C1) in the BD group. None of these correlations survived FDR protected significance levels for 27 correlations, which may be due to small sample size. The findings may support associations between subsyndromal manic and depressive symptoms and reelin receptor VLDLR, demethylation gene TET3, cytokines IL-6 and IL-1B, and glucocorticoid receptor NR3C1 linked to abnormal neural growth.

Frontiers in PsychiatryVol. 17
University of North Carolina at Chapel Hill (US), Nathan Kline Institute for Psychiatric Research (US), Pennsylvania State University (US), University of Illinois Chicago (US), New York University (US)
Bipolar Disorder and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon